Your browser doesn't support javascript.
loading
Design and Development of Novel 4-(4-(1H-Tetrazol-5-yl)-1H-pyrazol-1-yl)-6-morpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine as Cardiotonic Agent via Inhibition of PDE3.
Mao, Zhi-Wei; Li, Qiao-Ling; Wang, Ping; Sun, Yang-Li; Liu, Yu.
Affiliation
  • Mao ZW; Department of Cardiovasology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, P. R. China.
  • Li QL; Department of Kidney Rheumatology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China.
  • Wang P; Department of Cardiovasology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, P. R. China.
  • Sun YL; Department of Cardiovasology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, P. R. China.
  • Liu Y; Department of Cardiovasology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, P. R. China.
Arch Pharm (Weinheim) ; 349(4): 268-76, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26934198
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazines / Cardiotonic Agents / Cyclic Nucleotide Phosphodiesterases, Type 3 / Phosphodiesterase 3 Inhibitors Limits: Animals Language: En Journal: Arch Pharm (Weinheim) Year: 2016 Document type: Article Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazines / Cardiotonic Agents / Cyclic Nucleotide Phosphodiesterases, Type 3 / Phosphodiesterase 3 Inhibitors Limits: Animals Language: En Journal: Arch Pharm (Weinheim) Year: 2016 Document type: Article Country of publication: Germany